Results 291 to 300 of about 130,425 (315)

KRAS

2011
openaire   +1 more source

Cracking KRAS

Nature Reviews Drug Discovery, 2019
openaire   +1 more source

Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase

Nature Medicine, 2018
Dietrich A Ruess, Kıvanç Görgülü, Kalliope N Diakopoulos   +2 more
exaly  

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes

Nature, 2018
Thomas Engleitner, Roman Maresch, Sebastian Lange   +2 more
exaly  

KRAS

2014
openaire   +1 more source

SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo

Nature Medicine, 2018
Giovanni Germano, Jeffrey D Steinberg, Niels de Wit   +2 more
exaly  

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

Nature Reviews Clinical Oncology, 2009
Nicola Normanno, Floriana Morgillo, Antonella De Luca   +2 more
exaly  

Proto-Kra

Linguistics of the Tibeto-Burman Area, 2000
openaire   +1 more source

A combinatorial strategy for treating KRAS-mutant lung cancer

Nature, 2016
Eusebio Manchado, Chi-Chao Chen, Amaia Lujambio   +2 more
exaly  

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Nature Medicine, 2018
Jin Zhou, Zhong Wu, Steven E Schumacher
exaly